These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Timeliness and completeness of vaccination and risk factors for low and late vaccine uptake in young children living in rural southern Tanzania. Le Polain de Waroux O, Schellenberg JR, Manzi F, Mrisho M, Shirima K, Mshinda H, Alonso P, Tanner M, Schellenberg DM. Int Health; 2013 Jun; 5(2):139-47. PubMed ID: 24030114 [Abstract] [Full Text] [Related]
4. Improved coverage and timing of childhood vaccinations in two post-Soviet countries, Armenia and Kyrgyzstan. Schweitzer A, Krause G, Pessler F, Akmatov MK. BMC Public Health; 2015 Aug 19; 15():798. PubMed ID: 26285702 [Abstract] [Full Text] [Related]
8. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau. Fisker AB, Ravn H, Rodrigues A, Østergaard MD, Bale C, Benn CS, Aaby P. Vaccine; 2014 Jan 23; 32(5):598-605. PubMed ID: 24325827 [Abstract] [Full Text] [Related]
12. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials. Crawley J, Sismanidis C, Goodman T, Milligan P, WHO Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization in infants receiving Intermittent Preventive Treatment for malaria. Lancet; 2012 Sep 15; 380(9846):1001-10. PubMed ID: 22850358 [Abstract] [Full Text] [Related]
13. Timeliness of childhood vaccinations in Armenia, 2015-2016. Agopian A, Young H, Quinlan S, Rice MM. Vaccine; 2020 Jun 19; 38(30):4671-4678. PubMed ID: 32448619 [Abstract] [Full Text] [Related]
14. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov. Pediatrics; 2005 Aug 19; 116(2):e285-94. PubMed ID: 16061582 [Abstract] [Full Text] [Related]
15. Country-level predictors of vaccination coverage and inequalities in Gavi-supported countries. Arsenault C, Johri M, Nandi A, Mendoza Rodríguez JM, Hansen PM, Harper S. Vaccine; 2017 Apr 25; 35(18):2479-2488. PubMed ID: 28365251 [Abstract] [Full Text] [Related]
16. Expanded programme on immunization (EPI). Immunization schedules in the WHO African region, 1995. Wkly Epidemiol Rec; 1996 Mar 22; 71(12):90-4. PubMed ID: 8901335 [Abstract] [Full Text] [Related]
17. Avoiding missed opportunities for immunization in the Central African Republic: potential impact on vaccination coverage. Kahn JG, Mokdad AH, Deming MS, Roungou JB, Boby AM, Excler JL, Waldman RJ. Bull World Health Organ; 1995 Mar 22; 73(1):47-55. PubMed ID: 7704925 [Abstract] [Full Text] [Related]
18. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C. P N G Med J; 2001 Mar 22; 44(1-2):6-16. PubMed ID: 12418673 [Abstract] [Full Text] [Related]